US Patent Issued to Flamel Ireland on Oct. 20 for "Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" (French Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,122, issued on Oct. 20, was assigned to Flamel Ireland Ltd. (Dublin).

"Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" was invented by Claire Megret (Lyons, France), Herve Guillard (Villeurbanne, France), Jean-Francois Dubuisson (Lyons, France) and Jordan Dubow (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof."

The patent was filed on Dec. 12, 2025, under Application No. 19/418,323.

*For further information, including images, charts and tables...